The evolution of non-small cell lung cancer metastases in TRACERx.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
21
10
2021
accepted:
12
01
2023
medline:
21
4
2023
pubmed:
13
4
2023
entrez:
12
4
2023
Statut:
ppublish
Résumé
Metastatic disease is responsible for the majority of cancer-related deaths
Identifiants
pubmed: 37046095
doi: 10.1038/s41586-023-05729-x
pii: 10.1038/s41586-023-05729-x
pmc: PMC10115651
doi:
Banques de données
ClinicalTrials.gov
['NCT01888601']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
534-542Subventions
Organisme : Cancer Research UK
ID : 25354
Pays : United Kingdom
Organisme : Cancer Research UK
ID : CTRNBC-2022/100001
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 25349
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 21999
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 24956
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 17786
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : CC2008
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V033077/1
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : CC2041
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 29569
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 30025
Pays : United Kingdom
Investigateurs
Jason F Lester
(JF)
Amrita Bajaj
(A)
Apostolos Nakas
(A)
Azmina Sodha-Ramdeen
(A)
Keng Ang
(K)
Mohamad Tufail
(M)
Mohammed Fiyaz Chowdhry
(MF)
Molly Scotland
(M)
Rebecca Boyles
(R)
Sridhar Rathinam
(S)
Claire Wilson
(C)
Domenic Marrone
(D)
Sean Dulloo
(S)
Gurdeep Matharu
(G)
Jacqui A Shaw
(JA)
Joan Riley
(J)
Lindsay Primrose
(L)
Ekaterini Boleti
(E)
Heather Cheyne
(H)
Mohammed Khalil
(M)
Shirley Richardson
(S)
Tracey Cruickshank
(T)
Sarah Benafif
(S)
Kayleigh Gilbert
(K)
Akshay J Patel
(AJ)
Aya Osman
(A)
Christer Lacson
(C)
Gerald Langman
(G)
Helen Shackleford
(H)
Madava Djearaman
(M)
Salma Kadiri
(S)
Angela Leek
(A)
Jack Davies Hodgkinson
(JD)
Nicola Totten
(N)
Angeles Montero
(A)
Elaine Smith
(E)
Eustace Fontaine
(E)
Felice Granato
(F)
Helen Doran
(H)
Juliette Novasio
(J)
Kendadai Rammohan
(K)
Leena Joseph
(L)
Paul Bishop
(P)
Rajesh Shah
(R)
Stuart Moss
(S)
Vijay Joshi
(V)
Philip Crosbie
(P)
Fabio Gomes
(F)
Kate Brown
(K)
Mathew Carter
(M)
Anshuman Chaturvedi
(A)
Lynsey Priest
(L)
Pedro Oliveira
(P)
Matthew G Krebs
(MG)
Alexandra Clipson
(A)
Jonathan Tugwood
(J)
Alastair Kerr
(A)
Dominic G Rothwell
(DG)
Elaine Kilgour
(E)
Hugo J W L Aerts
(HJWL)
Roland F Schwarz
(RF)
Tom L Kaufmann
(TL)
Rachel Rosenthal
(R)
Zoltan Szallasi
(Z)
Judit Kisistok
(J)
Mateo Sokac
(M)
Miklos Diossy
(M)
Jonas Demeulemeester
(J)
Aengus Stewart
(A)
Alastair Magness
(A)
Angeliki Karamani
(A)
Benny Chain
(B)
Brittany B Campbell
(BB)
Carla Castignani
(C)
Chris Bailey
(C)
Clare Puttick
(C)
Clare E Weeden
(CE)
Claudia Lee
(C)
Corentin Richard
(C)
David R Pearce
(DR)
Despoina Karagianni
(D)
Dhruva Biswas
(D)
Dina Levi
(D)
Elena Hoxha
(E)
Elizabeth Larose Cadieux
(E)
Eva Grönroos
(E)
Felip Gálvez-Cancino
(F)
Foteini Athanasopoulou
(F)
Francisco Gimeno-Valiente
(F)
George Kassiotis
(G)
Georgia Stavrou
(G)
Gerasimos Mastrokalos
(G)
Haoran Zhai
(H)
Helen L Lowe
(HL)
Ignacio Matos
(I)
Jacki Goldman
(J)
James L Reading
(JL)
James R M Black
(JRM)
Javier Herrero
(J)
Jayant K Rane
(JK)
Jerome Nicod
(J)
Jie Min Lam
(JM)
John A Hartley
(JA)
Katey S S Enfield
(KSS)
Kayalvizhi Selvaraju
(K)
Kerstin Thol
(K)
Kevin Litchfield
(K)
Kevin W Ng
(KW)
Kezhong Chen
(K)
Krijn Dijkstra
(K)
Krupa Thakkar
(K)
Leah Ensell
(L)
Mansi Shah
(M)
Marcos Vasquez
(M)
Maria Litovchenko
(M)
Mariana Werner Sunderland
(M)
Michelle Leung
(M)
Mickael Escudero
(M)
Mihaela Angelova
(M)
Miljana Tanić
(M)
Monica Sivakumar
(M)
Nnennaya Kanu
(N)
Olga Chervova
(O)
Olivia Lucas
(O)
Othman Al-Sawaf
(O)
Philip Hobson
(P)
Piotr Pawlik
(P)
Robert Bentham
(R)
Robert E Hynds
(RE)
Roberto Vendramin
(R)
Sadegh Saghafinia
(S)
Saioa López
(S)
Samuel Gamble
(S)
Seng Kuong Anakin Ung
(SKA)
Sharon Vanloo
(S)
Stefan Boeing
(S)
Stephan Beck
(S)
Supreet Kaur Bola
(SK)
Tamara Denner
(T)
Teresa Marafioti
(T)
Thanos P Mourikis
(TP)
Victoria Spanswick
(V)
Vittorio Barbè
(V)
Wei-Ting Lu
(WT)
William Hill
(W)
Wing Kin Liu
(WK)
Yin Wu
(Y)
Yutaka Naito
(Y)
Zoe Ramsden
(Z)
Catarina Veiga
(C)
Gary Royle
(G)
Charles-Antoine Collins-Fekete
(CA)
Francesco Fraioli
(F)
Paul Ashford
(P)
Tristan Clark
(T)
Elaine Borg
(E)
James Wilson
(J)
Davide Patrini
(D)
Emilie Martinoni Hoogenboom
(E)
Fleur Monk
(F)
James W Holding
(JW)
Junaid Choudhary
(J)
Kunal Bhakhri
(K)
Marco Scarci
(M)
Martin Hayward
(M)
Nikolaos Panagiotopoulos
(N)
Pat Gorman
(P)
Reena Khiroya
(R)
Robert C M Stephens
(RCM)
Yien Ning Sophia Wong
(YNS)
Steve Bandula
(S)
Abigail Sharp
(A)
Sean Smith
(S)
Nicole Gower
(N)
Harjot Kaur Dhanda
(HK)
Kitty Chan
(K)
Camilla Pilotti
(C)
Rachel Leslie
(R)
Anca Grapa
(A)
Hanyun Zhang
(H)
Khalid AbdulJabbar
(K)
Xiaoxi Pan
(X)
Yinyin Yuan
(Y)
David Chuter
(D)
Mairead MacKenzie
(M)
Serena Chee
(S)
Aiman Alzetani
(A)
Lydia Scarlett
(L)
Jennifer Richards
(J)
Papawadee Ingram
(P)
Silvia Austin
(S)
Eric Lim
(E)
Paulo De Sousa
(P)
Simon Jordan
(S)
Alexandra Rice
(A)
Hilgardt Raubenheimer
(H)
Harshil Bhayani
(H)
Lyn Ambrose
(L)
Anand Devaraj
(A)
Hema Chavan
(H)
Sofina Begum
(S)
Silviu I Buderi
(SI)
Daniel Kaniu
(D)
Mpho Malima
(M)
Sarah Booth
(S)
Andrew G Nicholson
(AG)
Nadia Fernandes
(N)
Pratibha Shah
(P)
Chiara Proli
(C)
Madeleine Hewish
(M)
Sarah Danson
(S)
Michael J Shackcloth
(MJ)
Lily Robinson
(L)
Peter Russell
(P)
Craig Dick
(C)
John Le Quesne
(J)
Alan Kirk
(A)
Mo Asif
(M)
Rocco Bilancia
(R)
Nikos Kostoulas
(N)
Mathew Thomas
(M)
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023. The Author(s).
Références
Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
pubmed: 30207593
doi: 10.3322/caac.21492
Zappa, C. & Mousa, S. A. Non-small cell lung cancer: current treatment and future advances. Transl. Lung Cancer Res. 5, 288–300 (2016).
pubmed: 27413711
pmcid: 4931124
doi: 10.21037/tlcr.2016.06.07
Jamal-Hanjani, M. et al. Tracking the evolution of non–small-cell lung cancer. N. Engl. J. Med. 376, 2109–2121 (2017).
pubmed: 28445112
doi: 10.1056/NEJMoa1616288
Grigoriadis, K. et al. CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction. Protoc. Exchange https://doi.org/10.21203/rs.3.pex-2158/v1 (2023).
de Bruin, E. C. et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251–256 (2014).
pubmed: 25301630
pmcid: 4636050
doi: 10.1126/science.1253462
Pich, O. et al. The mutational footprints of cancer therapies. Nat. Genet. 51, 1732–1740 (2019).
pubmed: 31740835
pmcid: 6887544
doi: 10.1038/s41588-019-0525-5
Landau, H. J. et al. Accelerated single cell seeding in relapsed multiple myeloma. Nat. Commun. 11, 3617 (2020).
pubmed: 32680998
pmcid: 7368016
doi: 10.1038/s41467-020-17459-z
Pich, O. et al. The evolution of hematopoietic cells under cancer therapy. Nat. Commun. 12, 4803 (2021).
pubmed: 34376657
pmcid: 8355079
doi: 10.1038/s41467-021-24858-3
Sun, R. et al. Between-region genetic divergence reflects the mode and tempo of tumor evolution. Nat. Genet. 49, 1015–1024 (2017).
pubmed: 28581503
pmcid: 5643198
doi: 10.1038/ng.3891
Bueno, J., Landeras, L. & Chung, J. H. Updated Fleischner society guidelines for managing incidental pulmonary nodules: common questions and challenging scenarios. Radiographics 38, 1337–1350 (2018).
pubmed: 30207935
doi: 10.1148/rg.2018180017
Callister, M. E. J. et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax 70, ii1–ii54 (2015).
pubmed: 26082159
doi: 10.1136/thoraxjnl-2015-207168
Horeweg, N. et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol. 15, 1332–1341 (2014).
pubmed: 25282285
doi: 10.1016/S1470-2045(14)70389-4
de Koning, H. J. et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N. Engl. J. Med. 382, 503–513 (2020).
pubmed: 31995683
doi: 10.1056/NEJMoa1911793
Oudkerk, M. et al. European position statement on lung cancer screening. Lancet Oncol. 18, e754–e766 (2017).
pubmed: 29208441
doi: 10.1016/S1470-2045(17)30861-6
MacMahon, H. et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology 284, 228–243 (2017).
pubmed: 28240562
doi: 10.1148/radiol.2017161659
American College of Radiology Committee on Lung-RADS. Lung-RADS Assessment Categories version 1.1 (ACR, 2019); https://www.acr.org/-/media/ACR/Files/RADS/Lung-RADS/LungRADSAssessmentCategoriesv1-1.pdf.
Frankell, A. M. et al. The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature https://doi.org/10.1038/s41586-023-05783-5 (2023).
El-Kebir, M., Satas, G. & Raphael, B. J. Inferring parsimonious migration histories for metastatic cancers. Nat. Genet. 50, 718–726 (2018).
pubmed: 29700472
pmcid: 6103651
doi: 10.1038/s41588-018-0106-z
Abbosh, C. et al. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature https://doi.org/10.1038/s41586-023-05776-4 (2023).
Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029–1041 (2017).
pubmed: 29056346
pmcid: 5720395
doi: 10.1016/j.cell.2017.09.042
Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 174, 1034–1035 (2018).
pubmed: 30096302
pmcid: 8045146
doi: 10.1016/j.cell.2018.07.034
Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).
pubmed: 21527027
pmcid: 3218867
doi: 10.1186/gb-2011-12-4-r41
Lee, W.-C. et al. Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity. Genome Biol. 21, 271 (2020).
pubmed: 33148332
pmcid: 7640699
doi: 10.1186/s13059-020-02175-0
Brown, D. et al. Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations. Nat. Commun. 8, 14944 (2017).
pubmed: 28429735
pmcid: 5474888
doi: 10.1038/ncomms14944
Faltas, B. M. et al. Clonal evolution of chemotherapy-resistant urothelial carcinoma. Nat. Genet. 48, 1490–1499 (2016).
pubmed: 27749842
pmcid: 5549141
doi: 10.1038/ng.3692
Hu, Z. et al. Quantitative evidence for early metastatic seeding in colorectal cancer. Nat. Genet. 51, 1113–1122 (2019).
pubmed: 31209394
pmcid: 6982526
doi: 10.1038/s41588-019-0423-x
Naxerova, K. et al. Origins of lymphatic and distant metastases in human colorectal cancer. Science 357, 55–60 (2017).
pubmed: 28684519
pmcid: 5536201
doi: 10.1126/science.aai8515
Kim, T.-M. et al. Subclonal genomic architectures of primary and metastatic colorectal cancer based on intratumoral genetic heterogeneity. Clin. Cancer Res. 21, 4461–4472 (2015).
pubmed: 25979483
doi: 10.1158/1078-0432.CCR-14-2413
Zhao, Z.-M. et al. Early and multiple origins of metastatic lineages within primary tumors. Proc. Natl Acad. Sci. USA 113, 2140–2145 (2016).
pubmed: 26858460
pmcid: 4776530
doi: 10.1073/pnas.1525677113
Zhai, W. et al. The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma. Nat. Commun. 8, 4565 (2017).
pubmed: 28240289
pmcid: 5333358
doi: 10.1038/ncomms14565
Gibson, W. J. et al. The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. Nat. Genet. 48, 848–855 (2016).
pubmed: 27348297
pmcid: 4963271
doi: 10.1038/ng.3602
Reiter, J. G. et al. Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases. Nat. Genet. 52, 692–700 (2020).
pubmed: 32451459
pmcid: 7343611
doi: 10.1038/s41588-020-0633-2
Tang, W.-F. et al. Timing and origins of local and distant metastases in lung cancer. J. Thorac. Oncol. 16, 1136–1148 (2021).
pubmed: 33722707
doi: 10.1016/j.jtho.2021.02.023
Tan, Q. et al. Genomic alteration during metastasis of lung adenocarcinoma. Cell. Physiol. Biochem. 38, 469–486 (2016).
pubmed: 26828653
doi: 10.1159/000438644
Hu, Z., Li, Z., Ma, Z. & Curtis, C. Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. Nat. Genet. 52, 701–708 (2020).
pubmed: 32424352
pmcid: 7343625
doi: 10.1038/s41588-020-0628-z
Ullah, I. et al. Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes. J. Clin. Invest. 128, 1355–1370 (2018).
pubmed: 29480816
pmcid: 5873882
doi: 10.1172/JCI96149
Haffner, M. C. et al. Tracking the clonal origin of lethal prostate cancer. J. Clin. Invest. 123, 4918–4922 (2013).
pubmed: 24135135
pmcid: 3809798
doi: 10.1172/JCI70354
Noorani, A. et al. Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma. Nat. Genet. 52, 74–83 (2020).
pubmed: 31907488
pmcid: 7100916
doi: 10.1038/s41588-019-0551-3
Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353–357 (2015).
pubmed: 25830880
pmcid: 4413032
doi: 10.1038/nature14347
Chen, H.-N. et al. Genomic evolution and diverse models of systemic metastases in colorectal cancer. Gut 71, 322–332 (2022).
pubmed: 33632712
doi: 10.1136/gutjnl-2020-323703
Abbosh, C. et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545, 446–451 (2017).
pubmed: 28445469
pmcid: 5812436
doi: 10.1038/nature22364
Turajlic, S. et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell 173, 581–594 (2018).
pubmed: 29656895
pmcid: 5938365
doi: 10.1016/j.cell.2018.03.057
Bailey, C. et al. Tracking cancer evolution through the disease course. Cancer Discov. 11, 916–932 (2021).
pubmed: 33811124
pmcid: 7611362
doi: 10.1158/2159-8290.CD-20-1559
Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31 (2016).
pubmed: 26899170
pmcid: 4762164
doi: 10.1186/s13059-016-0893-4
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94–101 (2020).
pubmed: 32025018
pmcid: 7054213
doi: 10.1038/s41586-020-1943-3
Boot, A. et al. In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors. Genome Res. 28, 654–665 (2018).
pubmed: 29632087
pmcid: 5932606
doi: 10.1101/gr.230219.117
Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209–216 (2015).
pubmed: 25665006
pmcid: 4575589
doi: 10.1038/ng.3214
Cannataro, V. L., McKinley, S. A. & St Mary, C. M. The implications of small stem cell niche sizes and the distribution of fitness effects of new mutations in aging and tumorigenesis. Evol. Appl. 9, 565–582 (2016).
pubmed: 27099622
pmcid: 4831459
doi: 10.1111/eva.12361
Lebeuf-Taylor, E., McCloskey, N., Bailey, S. F., Hinz, A. & Kassen, R. The distribution of fitness effects among synonymous mutations in a gene under directional selection. eLife 8, e45952 (2019).
pubmed: 31322500
pmcid: 6692132
doi: 10.7554/eLife.45952
Eyre-Walker, A. & Keightley, P. D. The distribution of fitness effects of new mutations. Nat. Rev. Genet. 8, 610–618 (2007).
pubmed: 17637733
doi: 10.1038/nrg2146
Bozic, I. et al. Accumulation of driver and passenger mutations during tumor progression. Proc. Natl Acad. Sci. USA 107, 18545–18550 (2010).
pubmed: 20876136
pmcid: 2972991
doi: 10.1073/pnas.1010978107
Williams, M. J. et al. Measuring the distribution of fitness effects in somatic evolution by combining clonal dynamics with dN/dS ratios. eLife 9, e48714 (2020).
pubmed: 32223898
pmcid: 7105384
doi: 10.7554/eLife.48714
Turajlic, S., Sottoriva, A., Graham, T. & Swanton, C. Resolving genetic heterogeneity in cancer. Nat. Rev. Genet. 20, 404–416 (2019).
pubmed: 30918367
doi: 10.1038/s41576-019-0114-6
Venkatesan, S. et al. Induction of APOBEC3 exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution. Cancer Discov. 11, 2456–2473 (2021).
pubmed: 33947663
pmcid: 8487921
doi: 10.1158/2159-8290.CD-20-0725
Dewhurst, S. M. et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 4, 175–185 (2014).
pubmed: 24436049
pmcid: 4293454
doi: 10.1158/2159-8290.CD-13-0285
Werner, B. et al. Measuring single cell divisions in human tissues from multi-region sequencing data. Nat. Commun. 11, 1035 (2020).
pubmed: 32098957
pmcid: 7042311
doi: 10.1038/s41467-020-14844-6
Del Monte, U. Does the cell number 10
pubmed: 19176997
doi: 10.4161/cc.8.3.7608
McGranahan, N. et al. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci. Transl. Med. 7, 283ra54 (2015).
pubmed: 25877892
pmcid: 4636056
doi: 10.1126/scitranslmed.aaa1408
Berger, A. H. et al. High-throughput phenotyping of lung cancer somatic mutations. Cancer Cell 30, 214 (2016).
pubmed: 27478040
pmcid: 5003022
doi: 10.1016/j.ccell.2016.06.022
Lawson, A. R. J. et al. Extensive heterogeneity in somatic mutation and selection in the human bladder. Science 370, 75–82 (2020).
pubmed: 33004514
doi: 10.1126/science.aba8347
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289–300 (1995).
Watkins, T. B. K. et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587, 126–132 (2020).
pubmed: 32879494
pmcid: 7611706
doi: 10.1038/s41586-020-2698-6
Frankell A. M., Colliver E., Mcgranahan N., Swanton C. cloneMap: a R package to visualise clonal heterogeneity. Preprint at bioRxiv https://doi.org/10.1101/2022.07.26.501523 (2022).